Incentives for Moving

This study has suspended participant recruitment.
(Enrollment has not begun; study suspended indefinitely due to change in management at company where we were going to conduct the study.)
Sponsor:
Collaborators:
University of California, Berkeley
Carnegie Mellon University
Information provided by (Responsible Party):
Michael Norton, Harvard University
ClinicalTrials.gov Identifier:
NCT01278680
First received: January 18, 2011
Last updated: March 15, 2012
Last verified: March 2012

January 18, 2011
March 15, 2012
February 2011
April 2013   (final data collection date for primary outcome measure)
Walkstation usage [ Time Frame: 45 days ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01278680 on ClinicalTrials.gov Archive Site
  • Questionnaire [ Time Frame: baseline; 45 days; 90 days ] [ Designated as safety issue: No ]
    Participants will be asked to complete a questionnaire that assesses job satisfaction, personal well-being, and health behaviors
  • Walkstation usage [ Time Frame: 90 days ] [ Designated as safety issue: No ]
  • Biometrics [ Time Frame: baseline & 45 days ] [ Designated as safety issue: No ]
    Height, weight, and blood pressure
Same as current
Not Provided
Not Provided
 
Incentives for Moving
Not Provided

Employees of Blue Shield of California (BSC) will be recruited to participate to regularly use Walkstations. Some participants will be randomly assigned to a "hold out" control condition and the remainder will be assigned to one of two experimental treatments: Personal Incentive vs. Charitable Incentive. In the Personal Incentive condition people will be paid $3 for every completed Walkstation session, whereas for participants in the Charitable Incentive condition $3 will be donated to a specific charity. The incentives will operate for approximately 45 days and then for an additional 45 days participants in the two experimental conditions will have access to the Walkstations. Participants in the hold out control condition will begin using the Walkstations after the initial 90 day period.

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Sedentary Lifestyle; Obesity; General Well-being
Behavioral: Incentives for walkstation usage
The investigators are testing the effect of two different incentive schemes on people's usage of walkstations at work: either a personal incentive (in which people receive personal financial benefit for using the walkstations) vs. a charitable incentive (in which others receive financial benefit if a given individual uses the walkstation).
  • No Intervention: Hold-out control
    Hold-out control: participants will be asked to refrain from using the walkstations for the duration of the study (90 days).
  • Active Comparator: Personal incentive
    Personal incentive: Participants will receive $3 for each time they use the walkstation.
    Intervention: Behavioral: Incentives for walkstation usage
  • Experimental: Charitable incentive
    Charitable incentive: $3 will be donated to charity every time the participant uses the walkstation.
    Intervention: Behavioral: Incentives for walkstation usage
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Suspended
120
April 2013
April 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Must pass the ParQ

Exclusion Criteria:

  • Ineligible if person did not pass ParQ AND did not provide doctor's note authorizing their participation.
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT01278680
Walkstation3
Yes
Michael Norton, Harvard University
Harvard University
  • University of California, Berkeley
  • Carnegie Mellon University
Not Provided
Harvard University
March 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP